Grand Valley State University

ScholarWorks@GVSU
Masters Theses

Graduate Research and Creative Practice

8-15-2017

Influence of Socioeconomic Status on Event-Free
Survival in Children Diagnosed with Acute
Lymphoblastic Leukemia
Jordan L. Chester
Grand Valley State University

Follow this and additional works at: http://scholarworks.gvsu.edu/theses
Part of the Public Health Commons
Recommended Citation
Chester, Jordan L., "Influence of Socioeconomic Status on Event-Free Survival in Children Diagnosed with Acute Lymphoblastic
Leukemia" (2017). Masters Theses. 862.
http://scholarworks.gvsu.edu/theses/862

This Thesis is brought to you for free and open access by the Graduate Research and Creative Practice at ScholarWorks@GVSU. It has been accepted
for inclusion in Masters Theses by an authorized administrator of ScholarWorks@GVSU. For more information, please contact
scholarworks@gvsu.edu.

Influence of Socioeconomic Status on Event-Free Survival in Children Diagnosed with Acute
Lymphoblastic Leukemia
Jordan Lee Chester

A Thesis Submitted to the Graduate Faculty of
GRAND VALLEY STATE UNIVERSITY
In
Partial Fulfillment of the Requirements
For the Degree of
Master of Public Health

Public Health

August 2017

Acknowledgements
First and foremost, I would like to thank my thesis committee members, Dr. Karen
Niemchick and Dr. Nicholas Andersen, for their guidance throughout this process. Each of you
helped to provide me with a different perspective of looking at things for this research study, and
for that I could not be more thankful. A special thanks goes to my committee chair, Dr. Jeffrey
Wing, for the countless time put forth to get me to this point. Words cannot express how thankful
I have been over this past year for your help and support. To my friends and family, thank you
for your words of encouragement over the past year. Mom and dad, you have always been my
cheerleaders in life, and this research study was no different. I love you and could not be more
blessed to have parents like you. Lastly, I would like to thank my fellow thesis partner, Samantha
Lamkin, for her support and ability to answer all the questions I could ever think of. We did it!

3

Abstract
Acute lymphoblastic leukemia (ALL) is the most common type of cancer diagnosed in
children. However, little is known about how socioeconomic status (SES) influences the
outcomes of children diagnosed with ALL. The goal of the research study was to understand how
SES impacted the outcomes of children diagnosed with ALL, with a particular interest in
children living in West Michigan. Children ages 0-14 years who received treatment for ALL at
Spectrum Health’s Helen DeVos Children’s Hospital’s Pediatric Hematology and Oncology
program between the years 2002-2011 were considered for this study. Eligible participant’s zip
codes and dates of relapse/death were obtained through retrospective chart reviews to investigate
the association of interest. Zip codes were utilized to create neighborhood SES scores based on
census data related to education, occupation, and household income. Time to relapse/death was
determined to calculate five-year event-free survival. Differences in survival across
socioeconomic tertiles were evaluated using Kaplan-Meier survival analysis, with Coxproportional hazard regression conducted to describe the association between all collected
variables. Statistical analyses revealed that children of higher socioeconomic standing were
shown to have an increased risk of relapse or death compared to children of lower
socioeconomic standing, however these findings did not show a statistically significant
difference between the neighborhood socioeconomic tertiles. Although previous research has
shown that those of higher SES tend to have better overall health and better health outcomes,
compared to those of lower SES, this research study suggests that these differences may not
always occur as expected. Decreased exposure to early childhood infectious agents by way of
improved hygiene and changes in childcare may explain why children of higher socioeconomic
may be at greater risk of poor health outcomes compared to those of lower socioeconomic
standing. These findings may also indicate that differences in outcomes between various
4

socioeconomic groups may have diminished over the period of interest through the use of better
health communication and health services.
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Meaning
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Better outcome compared to reference population

=
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‡

p<0.05

*

Adjusted for neighborhood socioeconomic status scores (based on
tertiles created), age, race, and sex

†

Adjusted for neighborhood socioeconomic status scores (based on
tertiles created), age, race, sex, immunophenotype, and white
blood cell count at diagnosis
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I. Introduction
Leukemia is a form of blood/bone marrow cancer that affects people of all ages. While
many types of leukemia exist within nature, children under the age of 15 years are more notably
diagnosed with acute lymphoblastic leukemia (ALL), the most common type of cancer for this
age group (United States Cancer Statistics Working Group, 2016). Between the years 2009-2013,
the incidence rate for all leukemias in children ages 0-14 was 5.23 cases per 100,000 children
(United States Cancer Statistics Working Group, 2016). Leukemias of lymphoid origin
accounted for 4.00 of those cases (United States Cancer Statistics Working Group, 2016). A
variety of risk factors for this disease exist, including genetic mutations and environmental
exposures, however most patients do not have any of the known risk factors for leukemia
(Hunger & Mullighan, 2015). Similarly, little is known about how some factors, such as
socioeconomic status and race/ethnicity, influence patient outcomes among those that have been
diagnosed with ALL. Lower socioeconomic status has been associated with worse outcomes for
many health problems across the world, however its influence on the outcomes of those
diagnosed with ALL is not well understood (Demakakos, Nazroo, Breeze, & Marmot, 2008).
And although the association between socioeconomic status and ALL outcomes has been studied
by other researchers, few studies have been conducted within the United States, with none
looking specifically at a West Michigan population (Bona, Blonquist, Neuberg, Silverman, &
Wolfe, 2016; Charalampopoulou et al., 2004; Erdmann et al., 2014; Gupta, Sutradhar, Guttmann,
Sung, & Pole, 2014; Gupta, Wilejto, Pole, Guttmann, & Sung, 2014; Kent, Sender, Largent, &
Anton-Culver, 2009; Lightfoot et al., 2012; Metzger et al., 2003; Njoku, Basta, Mann, McNally,
& Pearce, 2013; Petridou et al., 2015; Sergentanis et al., 2013; Son, Kim, Oh, & Kawachi, 2011;
Viana, Fernandes, de Carvalho, & Murao, 1998).
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Purpose
The purpose of this research study is to determine if there is a difference in five-year
event-free survival among West Michigan children diagnosed with ALL living in various
socioeconomic standings.
Scope
This study will be used to determine if there is a difference in event-free survival for
children diagnosed with ALL among different socioeconomic groups studied. The study
population will be defined as children receiving pediatric cancer care for ALL from Spectrum
Health’s Helen DeVos Children’s Hospital’s Pediatric Hematology and Oncology program who
live within a specific set of counties in West Michigan. For children diagnosed with ALL
between January 1, 2002 and December 31, 2011 who meet the inclusion criteria stated above,
demographic information, as well as leukocyte count at diagnosis, age at diagnosis,
immunophenotype of the child’s cancer, and zip code will be collected via electronic medical
record (EMR) review to assess for potential differences in survival based on neighborhood
socioeconomic scores.
Hypothesis
Null Hypothesis (H0): there is no difference in survival between those with lower
socioeconomic status and those with higher socioeconomic status
Alternative Hypothesis (Ha): there is a difference in survival between those with lower
socioeconomic status and those with higher socioeconomic status
Although the formal hypotheses are stated as being two-sided to allow for a difference in
either direction, the researcher hypothesizes that there will be difference in survival by the level
of socioeconomic status, with children of lower socioeconomic standing having worse outcomes
compared to children of higher socioeconomic standing. People of higher socioeconomic
13

standing tend to have better overall health and better health outcomes, compared to those of
lower socioeconomic standing (Demakakos et al., 2008). Among studies that looked at
socioeconomic status’ influence on ALL outcomes within the United States, most of the studies
found differences in survival between different socioeconomic groups, with those being of lower
socioeconomic standing having worse ALL outcomes, further supporting the researcher’s
hypothesis (Abrahão et al., 2015; Acharya et al., 2016; Kent et al., 2009).
Significance
Due to the previous establishment of socioeconomic status’ influence on health outcomes
for a variety of health problems, it is imperative that individuals understand its impact on those
diagnosed with ALL. As of 2016, Michigan ranked seventh within the United States for
estimated new cases of leukemia with 1,890 possible new cases (Siegel, Miller, & Jemal, 2016).
Michigan also ranked eighth within the United States for estimated deaths from leukemia, with
850 possible deaths likely to have occurred in 2016 (Siegel et al., 2016). While this study will
only look at those diagnosed with ALL within West Michigan, the understanding of this possible
difference in survival among various socioeconomic groups can allow doctors and communities
to tailor their accommodations for these cancer patients on a one-to-one basis. While treatment
protocols typically remain the same for all pediatric patients diagnosed with ALL, physicians
may be able to modify the types of conversations they are having with their various patients
based on their socioeconomic status.
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II. Literature Review
Acute lymphoblastic leukemia is known to have a variety of factors that can affect overall
survival and event-free survival. Each case of ALL is unique due to a combination of these
factors, which include leukocyte count at diagnosis, age at diagnosis, the patient and his or her
family’s socioeconomic status, the patient’s primary form of medical insurance, the patient’s
race and ethnicity, the immunophenotype and cytogenetics of the leukemic cells, and the sex of
the patient (Alperstein, Boren, & McNeer, 2015; Lustosa de Sousa, de Almeida Ferreira,
Cavalcante Félix, & de Oliveira Lopes, 2015; Teachey & Hunger, 2013). Many studies have
been designed to understand how these various factors influence outcomes in children with ALL,
however additional studies continue to be published due to the differences seen among different
places within the United States and the world. Other potential predictive factors of outcome in
ALL, such as the level of adherence to treatment therapy, the existence of a mediastinal mass,
and central nervous system involvement, have also been studied but have limited research to
confirm their predictive nature (Bhatia et al., 2012, 2014; Teachey & Hunger, 2013).
Nevertheless, it is important that all factors are discussed in order to understand how each
influence the outcome of the research question that will be studied.
Purpose
While many factors for ALL have been identified, some factors have various effects in
different parts of the world, namely socioeconomic status and form of health insurance.
Socioeconomic status is a complex entity that can be influenced by a variety of factors, such as
income, education, and occupation (Diez Roux et al., 2001). Socioeconomic status can also
impact health insurance opportunities, potentially limiting treatment options for children with
ALL. Thus, it is important that the effect of socioeconomic status is studied in various population
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settings to determine how it affects children who are diagnosed with ALL. However, other
factors also play an important role in the survival of children with ALL, therefore these
predictive factors will also be included within the study’s analyses. All factors will be discussed
to provide baseline knowledge of its known effects on children diagnosed with ALL.
Literature Synthesis
Leukocyte count at diagnosis. One of the primary prognostic factors used by the
National Cancer Institute to determine a child’s prognosis when first diagnosed with ALL is their
leukocyte, or white blood cell, count at diagnosis (n.d.). Hyperleukocytosis, or a leukocyte count
above the normal range of 3,500-10,500 cells/µL, has been described as an emergency situation
within the hematological oncology field, as it has been linked to early morbidity and mortality in
children (Mayo Foundation for Medical Education and Research, n.d.; Vaitkeviciene et al.,
2013). Children who are diagnosed with ALL and have a leukocyte count equal to or less than
50,000 cells/µL at diagnosis are considered to be standard risk patients, while those who have a
count of more than 50,000 cells/µL leukocytes are considered high risk patients (National Cancer
Institute, n.d.). These interpretations were consistent with Hunger and Mulligan’s (2015) and
Alperstein et al.’s (2015) research. Lustosa de Sousa et al. (2015) noted that patients who present
with hyperleukocytosis when first diagnosed with ALL may also arrive with other complications,
such as tumor masses, enlargement of the spleen and liver, and lymphadenopathy, further
impacting the patient’s prognosis. While hyperleukocytosis at diagnosis typically indicates
advanced disease state and a worse prognosis, strategies have been put in place to limit the
strength of treatment, as aggressive treatment plans can cause tumor lysis syndrome and be lethal
(Kong, Seo, Jun, Lee, & Lim, 2014). Although leukocyte count at diagnosis is one of the most
important prognostic factors for children diagnosed with ALL, age has also been shown to have a
strong impact on the outcomes of children with ALL.
16

Age at diagnosis. Few studies have openly discussed the significance that a child’s age at
the time of their ALL diagnosis has on their prognosis, however, the National Cancer Institute
(n.d.) recognizes this as one of its two primary prognostic factors. Teachey and Hunger (2013)
described age as a strong predictor of relapse, stating that children who are diagnosed with ALL
under the age of one year or above the age of nine years tend to have worse prognoses than
children ages 1-9 years. Wang, Bhatia, Gomez, and Yasui (2015) later determined that children
aged 0-1 year and 10 years and above had a much greater risk of death compared to children ages
1-9 years. Within their study, children less than one year of age were 7.57 times more likely to
die from ALL compared to children ages 1-9 years (Wang et al., 2015). Children 10 years and
above did not have as great of a risk of death, but were still 4.01 times more likely to die from
ALL compared to those ages 1-9 years (Wang et al., 2015) . Lustosa de Sousa et al.’s (2015)
study also showed a correlation between age at diagnosis and the prognosis of that child, as
children under the age of nine years had a five-year survival probability of 80%, compared to
55% for children over the age of nine years (Lustosa de Sousa et al., 2015). An earlier study by
Khalid, Moiz, Adil, and Khurshid (2010) showed that only age and immunophenotype had a
significant influence on a child’s outcome status, although only 46 patients were included in their
studied. They found that 78% of the children diagnosed between ages 1-9 years (n=27) had
survived ALL for the 17-year duration of the study, compared to 0% of children under the age of
one year (n=2) and 53% over the age of nine years (n=17) (Khalid et al., 2010). Reasons for the
differences in survival rates based on age have been hypothesized, but few studies have
confirmed why these differences occur. Alperstein et al. (2015) mentioned that children younger
than one year of age typically have a very aggressive form on the disease compared to children
above the age of one year, possibly due to the rearrangement of the MLL gene, which is
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commonly found within these children (Wang et al., 2015). Similarly, children 10 years and
above are also likely to have gene rearrangements associated with poor prognoses, along with
having other unfavorable factors such as high leukocyte counts (Lustosa de Sousa et al., 2015).
Wang et al. (2015) discussed the limited access to pediatric clinical trials seen by children over
the age of nine years which may potentially impact the survival of this age group as well (Wang
et al., 2015). Unfortunately, many of these hypotheses remain unstudied, leaving doctors unsure
of why these differences occur, however it has been well documented that age at diagnosis is a
strong predictor of outcome in ALL.
Socioeconomic status. Although the National Cancer Institute (n.d.) only recognizes
leukocyte count at diagnosis and age as primary prognostic factors for children with ALL,
socioeconomic status has also been shown to be an important factor in the outcomes of these
children. Most studies discussed socioeconomic status by means of parental education levels,
monthly income, number of people living within one house, marital status, healthcare access,
area remoteness, along with a few other factors that were not frequently mentioned
(Charalampopoulou et al., 2004; Gupta, Sutradhar, et al., 2014; Petridou et al., 2015; Viana, et
al., 1998). While it has been shown that socioeconomic status has had an impact on other disease
outcomes, few studies have been conducted within the United States to understand the impact of
socioeconomic status on children with ALL and their event-free survival. However, worldwide
studies appeared to be more common, especially within developing countries. Differences in
study outcomes were noted between the United States and other countries across the world,
possibly due to variations in the structure of healthcare systems within these countries. Particular
attention should be given to studies conducted within the United States as it pertains to the area
of interest for this study.
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United States studies. Without having a national health care system, yet being
economically developed, the United States provides a unique perspective for the association
between socioeconomic status and ALL outcomes. Families who are considered economically
advantaged within the United States may not have issues getting access to treatment for their
child with ALL, yet those who are economically disadvantaged typically do not have the same
fate. And although treatment techniques for ALL have improved over the past few decades, a
global meta-analysis completed by Petridou et al. (2015) found that children who were
considered to have lower socioeconomic standing tended to be impacted by these changes in
treatment the least. Twenty-three studies specific to ALL were included within the meta-analysis
that assessed a variety of outcomes, such as overall survival, event-free survival, and post-relapse
survival (Petridou et al., 2015). Researchers found that specific indicators of socioeconomic
status, such as education, level of poverty, employment status, and household income, had a
significant impact on overall survival (Petridou et al., 2015). Differences were noted between the
countries included within the analysis, as studies done within the United States often saw
discrepancies in childhood ALL outcomes between different socioeconomic groups, while other
countries did not see these differences (Petridou et al., 2015). The following studies are the most
recent reports that look at the association between socioeconomic status and ALL outcomes in
children in the United States. Other studies have been conducted in previous decades, however
changes in treatment throughout the past few decades were thought to compromise the external
validity of those studies in comparison to today’s population.
In a study conducted across seven different tertiary care centers within the United States,
researchers reported an association between time to relapse and the calculated socioeconomic
status of the patient (Bona et al., 2016). Zip codes and United States Census Bureau data were
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utilized to create a measurement system of the socioeconomic status of a specific area, while
information on ALL diagnosis was extrapolated from the tertiary care centers (Bona et al., 2016).
The overall survival of children living with ALL was only 85% within high-poverty areas,
compared to 92% for those that lived in low-poverty areas, however no difference was observed
in event-free survival (Bona et al., 2016). However, among the studies completed within the
United States, this study was the only one to collect data via another source besides a state cancer
registry, possibly adding bias to the findings of this study. Those who had the means to seek
treatment from one of the Dana-Farber Cancer Institute Consortium centers may have been more
advantaged compared to those who did not, thus it is best to consider additional findings when
reviewing the significance of socioeconomic status’ impact on ALL outcomes in children.
By using the California Cancer Registry (CCR), Kent, Sender, Largent, and AntonCulver (2009) also completed a study on socioeconomic status’ influence on ALL outcomes. The
study was open to those aged 0-39 years and not specified by leukemia type, different from most
of the studies analyzed within this review. To understand the importance of socioeconomic status
on leukemia outcomes, Kent et al. (2009) utilized the CCR’s neighborhood socioeconomic status
variable, which was calculated using, “median educational attainment, median household
income, proportion below 200% of the federal poverty level, median house value, median rent,
percent employed, and proportion of the population with blue-collar employment (p. 1410).”
Results showed that among all types of leukemia, with the exception of chronic lymphocytic
leukemia, those living within the lowest socioeconomic quintile were shown to have a 31%
increased risk of death compared to those living within the highest socioeconomic quintile (Kent
et al., 2009). A similar study completed by Abrahão et al. (2015) found that children and young
adults with ALL, aged 0-19 years, who lived within the lowest socioeconomic quintile were seen

20

to have a 39% increase in the risk of death compared to those that lived in the highest
socioeconomic quintile. Following the conclusion of their study, Abrahão et al. (2015)
hypothesized that these results could be due to the migrant population seen in California, as
undocumented workers may not wish to seek medical attention for their child until they see it as
an absolute necessity, which could lead the child to becoming much sicker in a short period of
time. A study that looked at other high migration states found comparable results, supporting this
hypothesis. Acharya et al. (2016) used a study population composed of children, ages 0-18 years,
which resided in Florida or Texas. They found that those living in areas where 20-100% of the
people lived in poverty were at 2.16 times greater risk of death compared to those living in areas
where less than 5% of the people live in poverty, with areas having 5-20% of the population
living in poverty having 1.36 times the risk of death compared to that same group (Acharya et
al., 2016). As with Abrahão et al. (2015), Acharya et al. (2016) reported that more studies need
to be conducted within the United States to support this association. Although many other studies
have been conducted worldwide, few countries are structurally similar to the United States,
contributing to the possibility of differences occurring among the findings of each respective
study.
Worldwide studies. A vast assortment of studies have been conducted worldwide to
determine the effects of socioeconomic status upon children diagnosed with ALL. Studies
reviewed spanned across four out of the seven continents around the world, and included
countries such as Brazil, Canada, England/United Kingdom, Germany, Greece, Honduras,
Scotland, South Korea, and Wales (Charalampopoulou et al., 2004; Erdmann et al., 2014; Gupta,
Sutradhar, Guttman, Sung, & Pole, 2014; Lightfoot et al., 2012; Metzger et al., 2003; Njoku,
Basta, Mann, McNally, & Pearce, 2013; Sergentanis et al., 2013; Son, Kim, Oh, & Kawachi,
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2011; Viana, et al., 1998). The influence of socioeconomic status varies in each country due to
the unique social and governmental structure found in each, providing the importance of
studying each country individually.
Low to middle-income countries have continued to see inferior cure rates for ALL
compared to developed countries, as cure rates within these countries have remained near 35%
while developed countries often see cure rates of 80% or more (Metzger et al., 2003). With only
one treatment hospital available for all patients, Honduras often sees these reduced cure rates
(Metzger et al., 2003). Metzger et al. (2003) tried to identify the specific reasons for these poor
outcomes by studying children ages 0-18 years that were receiving treatment for ALL in
Honduras. Although socioeconomic variables were not available for their study, it was discussed
that these factors more than likely pertained to the worse outcomes seen within low- to middleincome countries. Metzger et al. (2003) identified that the most common reason for treatment
failure was due to treatment abandonment, possibly influenced by lack of transportation to the
hospital, lack of parental education, or general non-compliance. A study from El Salvador found
that maternal illiteracy, presence of a central line, and the belief that weather caused fever were
all associated with sepsis in children diagnosed with either ALL or acute myelogenous leukemia
(AML), further relating poor outcomes in children with leukemia to lack of parental education, a
factor of socioeconomic status (Gavidia et al., 2012). Within Brazil, children with ALL that had
lower socioeconomic standing had 2.51 times the risk of relapse compared to children with
higher socioeconomic standing (Viana, et al., 1998). Viana et al. (1998) evaluated
socioeconomic status using a questionnaire that assessed various socioeconomic factors for each
child’s family. These factors included number of individuals living under one roof, monthly
income for each individual in the family, general electric consumption, physical characteristics
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of each family’s house, feeding habits of the family, sources of entertainment for the family,
mechanisms used by the family to cope, and the family’s level of perception of leukemia (Viana,
et al., 1998). This thorough assessment added strength to the association found between
socioeconomic status and risk of relapse. Among the studies reviewed, Central and South
American countries continued to struggle to have higher cure rates for leukemia compared to
other parts of the world, more than likely due to lower socioeconomic standings among their
citizens. However, low- and middle-income countries were not the only ones that faced these
issues, as some developed countries have also experienced these associations as well.
Developed countries such as England/United Kingdom, Scotland, Wales, and Greece
have also seen associations between socioeconomic status and various ALL outcomes among
their children (Charalampopoulou et al., 2004; Lightfoot et al., 2012; Njoku et al., 2013;
Sergentanis et al., 2013). Furthermore, a study including all childhood cancers in South Korea
had similar findings (Son et al., 2011). Within this study, a birth cohort was established and
followed for 10 years, or until death occurred (Son et al., 2011). Death from cancer was analyzed
based on parental education and occupation found on birth certificates within the area studied
(Son et al., 2011). After stratifying specifically for children with leukemia, parental occupation
was the only socioeconomic variable seen to impact the mortality of the child (Son et al., 2011).
Similar findings occurred within a study conducted within England/United Kingdom (Njoku et
al., 2013). Njoku et al. (2013) studied socioeconomic status based upon the parental education
reported on the birth certificates of participating individuals. After collecting data on leukemia
(both ALL and AML) from the Northern Region Young Persons Malignant Disease Registry,
Njoku et al. (2013) found significantly decreased rates of survival at one-year, five-years, and
ten-years post-leukemia diagnosis. Researchers were somewhat surprised by these findings since
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England/United Kingdom has a national healthcare system where all treatments are free for
children diagnosed with leukemia (Njoku et al., 2013). It was hypothesized that these differences
could be due to the challenges in gaining access to the health care provided to the country’s
citizens (Njoku et al., 2013). Nonetheless, comparable results were also seen in a different study
done within England/United Kingdom, which also included Scotland and Wales into its analysis
(Lightfoot et al., 2012). Lightfoot et al. (2012) found that there was a greater risk of death at five
years post-diagnosis for those in the lower socioeconomic quintiles compared to individuals in
the higher socioeconomic quintiles. Although Njoku et al. (2013) and Lightfoot et al. (2012) had
similar findings, not all studies conducted within the same country showed similar findings at the
conclusion of their study.
Two studies in Greece investigated the effect of socioeconomic status on ALL outcomes
in children. Of the two studies carried out in Greece, one study used a nationwide registry
(Nationwide Registry for Childhood Hematological Malignancies) for their study population
while the other study used cases occurring within four Grecian hospitals across the country
(Charalampopoulou et al., 2004; Sergentanis et al., 2013). Within the study using the nationwide
registry, personal interviews were conducted to obtain information relating to a variety of
sociodemographic variables (Sergentanis et al., 2013). Parental job status significantly impacted
the outcomes of children with leukemia (either ALL or AML), as children who had parents with
lower professional statuses were seen to have a 40% decrease in survival compared to children
whose parents were in higher professions. Charalampopoulou et al. (2004) obtained data relating
to socioeconomic status at the time of diagnosis, but did not find any socioeconomic status
factors that statistically impacted survival in children with ALL. Both distance from treatment
facility and maternal schooling were shown to be suggestive of poor survival in the children

24

studied, however were not found to be statistically significant (p = 0.08 and 0.14, respectively).
Although the studies were completed during two different time periods (1996-2010 and 19962002) and used different methods of assessing socioeconomic status, it was expected that similar
results would be found (Charalampopoulou et al., 2004; Sergentanis et al., 2013). Nevertheless,
the differences in association found within Greece show the importance of studying different
areas within a country, as contrasting results can be found even in similar populations.
Although most of the studies reviewed found an association between socioeconomic
status and poor outcomes for children with ALL, two studies, along with Charalampopoulou et
al. (2014), did not observe an association. Gupta et al. (2014) studied children ages 0-18 years
living in Ontario, Canada who were diagnosed with ALL during the years 1995-2011.
Socioeconomic status was evaluated by using the patient’s zip code address and relating it to
median income quintiles for that particular neighborhood (Gupta et al., 2014). No association
between five-year event-free survival and socioeconomic status was seen after univariable and
multivariable analysis (Gupta et al., 2014). Similarly in West Germany, family income, maternal
education, and residential area had no influence on overall survival or event-free survival
(Erdmann et al., 2014). Cases of ALL were established through the German Childhood Cancer
Registry and were only included within the study if the child had been diagnosed between
October 1992 and September 1994 and was under the age of 15 at the time of diagnosis
(Erdmann et al., 2014). Socioeconomic status was evaluated via questionnaire or telephone
interview (Erdmann et al., 2014). Both studies postulated that the null association they concluded
was possibly due to the universal healthcare insurance provided to the citizens of each of the
countries studied, as it can help to prevent the cost of treatment from interfering with adequate
access to treatment for children with ALL (Erdmann et al., 2014; Gupta et al., 2014).
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Unfortunately, the lack of access to treatment continues to impact the outcomes of the child with
ALL in many other countries due to a variety of factors, including lack of health insurance and
the location of treatment centers.
As shown, differences in ALL outcomes based on socioeconomic status occur all over the
world and even differ among various areas of the United States. Different areas across the United
States and the world need to be further examined to better understand this association. It is
important to remember that ALL is the most common type of leukemia in children, accounting
for nearly 75-80% of all childhood leukemias, and accounts for nearly 25% of all childhood
cancers (Lustosa de Sousa et al., 2015; National Cancer Institute, n.d.). Nevertheless,
socioeconomic status has been shown to be influential among the outcomes of children
diagnosed with ALL. However, health insurance, an entity relating to one’s socioeconomic
status, may also impact ALL outcomes in children independently.
Studies involving health insurance. A limited number of studies have examined the
association between health insurance and leukemia outcomes. Of the studies reviewed, none
looked exclusively at leukemia outcomes in children, and only one studied the influence of
health insurance on patients with ALL. In the study that looked at outcomes among those with
ALL, only young adults 18-30 years of age were assessed to understand the influence of
insurance on overall survival (Fintel, Jamy, & Martin, 2015). Data was collected using the
Surveillance, Epidemiology, and End Results (SEER) database between the years 2007-2010,
and it was concluded that there was no statistical difference in the overall survival of the patients
studied based on health insurance (Fintel et al., 2015). However, in a study looking at patients
with AML, type of insurance was found to have an effect on overall survival (Master, Munker,
Shi, Mills, & Shi, 2016). Within this study, the National Cancer Database was used to study
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patients of all ages diagnosed with AML between the years 1998 and 2011 (Master et al., 2016).
Among the 67,443 patients included in the study, those that were uninsured had a 20% increased
risk of death from AML, while patients with Medicare or Medicaid had a 19% and 16%
increased risk of death from AML compared to those with private insurance (Master et al.,
2016). A study completed in Puerto Rico showed similar results, as those covered by the
government healthcare plan were at 1.6 times greater risk of death from leukemia compared to
those covered by a non-government healthcare plan (Ortiz-Ortiz et al., 2014). However, these
results were only seen among patients 65 years of age or older, meaning that these results do not
necessarily apply to children (Ortiz-Ortiz et al., 2014). Nonetheless, knowledge in this area of
study is limited, and further research in this field is needed.
Race and ethnicity. In children with ALL, race and ethnicity have commonly been
identified as possible prognostic factors. Numerous studies have shown that blacks, Hispanics,
and Native Americans have worse survival rates compared to non-Hispanic white children, while
Asian children have been shown to have differing survival rates compared to non-Hispanic white
children (Abrahão et al., 2015; Acharya et al., 2016; Bhatia et al., 2002; Goggins & Lo, 2012;
Hunger & Mullighan, 2015; Kadan-Lottick et al., 2003). Hunger and Mullighan (2015) stated
within their review that these differences in survival rates might be due to the difference in the
incidence of various genetic mutations among these races and ethnicities. For example, TCF3PBX1 ALL is more common in blacks, while the CRLF-2 ALL is more commonly found in
Hispanics (Hunger & Mullighan, 2015). Thus, genetic differences may confound the impact that
race and ethnicity have been shown to have.
Differences in survival between non-Hispanic white children and black, Hispanic, and
Native American children were reported within two of the studies reviewed (Bhatia et al., 2002;
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Kadan-Lottick et al., 2003). In these same studies, Asian children were not found to have
significantly different survival rates compared to non-Hispanic white children (Bhatia et al.,
2002; Kadan-Lottick et al., 2003). Although non-Hispanic white children were more commonly
represented within each of these studies, this skewed population distribution was expected, as
non-Hispanic white children tend to have higher rates of leukemia compared to other races and
ethnicities (McCance, Huether, Brashers, & Rote, 2010). Only Kadan-Lottick et al. (2003) were
able to capture a Native American population within their study, however the proportion of the
sample size represented by this population was minute. Nevertheless, black and Hispanic
children were found to be at significantly higher risk of poor outcomes in ALL compared to nonHispanic children within both studies, with Native American children having worse ALL
outcomes compared to non-Hispanic white children within Kadan-Lottick et al.’s (2003) study
(Bhatia et al., 2002). In contrast, Bhatia et al. (2002) found that Asian children were at decreased
risk of poor outcomes compared to non-Hispanic white children, however Kadan-Lottick et al.
(2003) reported that neither group experienced superior outcomes compared to the other. This
difference may have been due to a larger population size utilized by Kadan-Lottick et al. (2003),
but no other explanations for these differences could hypothesized by the researcher. Although
both studies had relatively large sample sizes (N=4,952 in Kadan-Lottick et al. [2003] and
N=8,447 in Bhatia et al. [2002]), the sample size for a specific race or ethnicity may have been
small, impacting the external validity of these results. This can be seen in Kadan-Lottick et al.’s
(2003) studying involving Native Americans, in which only 1.2% of the study population
identified as Native Americans.
Among the studies that did not find similar outcomes between Asian children and nonHispanic children, differences were still found between non-Hispanic white and black, Hispanic,
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and where applicable, Native American children (Abrahão et al., 2015; Acharya et al., 2016;
Goggins & Lo, 2012). Archarya et al. (2016) did not find similar outcomes between nonHispanic white children and Asian children since their study only compared the outcomes
between non-Hispanic white, Hispanic, and black children. Asian and Native American children
were excluded from their study due to low population sizes among all patients identified for their
study (Archarya et al. (2016). Similarly, Goggins and Lo (2012) further stratified Asian children
into the categories of East Asian (Chinese, Filipino, Korean, Japanese, Vietnamese, and other
Southeast Asian), Other Asian, and South Asian. Therefore, each of these subpopulations had
different findings with varying levels of significance. East Asian children were found to have an
increased risk of poor outcomes in ALL, as were black, Native American, and Hispanic children
when compared to non-Hispanic white children, however other Asian populations did not have
these same findings, possibly due to the small sample population seen within these racial groups
(Goggins & Lo, 2012). Abrahão et al. (2015) also found worse outcomes among Asian, black,
and Hispanic children when comapred to non-Hispanic children. Black children were seen to
have the worst outcomes of all races, having 1.78 times the risk of death compared to nonHispanic white children while Hispanic children were at 1.38 times greater risk and Asian
children at 1.33 times greater risk (Abrahão et al., 2015). Even so, it can be difficult to study the
association of ALL outcomes in children based upon race and ethinicity due to differences in the
distribution of ALL cases among all races and ethinicities, especially when studying different
areas across the world, thus all results should be reviewed with caution. A brief summary of all
the racial and ethnic studies reviewed can be found in Table 1.
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Table 1.
Differences in ALL outcomes in children based upon race and ethnicity by research study
Races and Ethnicities Studied
African
Non-Hispanic
American/Blac Asia White/Caucasia Hispani
Native
Authors
k
n
n
c
American
‡
‡
‡
↓
↓
↓
reference
n/a
Abrahão et al. (2015)
‡
‡
↓
↓
n/a
reference
n/a
Acharya et al. (2016)
‡
‡
‡
↑
↓
reference
n/a
↓
Bhatia et al. (2002)
‡
‡
↓
↓
↓‡
↑/↓
reference
Goggins & Lo (2012)
Kadan-Lottick et al.
↓‡
↓‡
↓‡
(=)
reference
(2003)
Note. ↓ indicates worse outcome compared to reference population; ↑ indicates better outcome
compared to reference population; and (=) indicates similar outcome compared to reference
population
‡ p<0.05

While a variety of studies have examined the correlation of race and ethnicity and ALL
outcomes in children, a lack of standardization and a large variance in the number of cases
among all races and ethnicities often makes it hard to compare these studies. A majority of the
studies assessed showed that black and Hispanic children often had the worst outcomes among
all races and ethnicities evaluated, with two studies finding the highest levels of risk in Native
American children (Abrahão et al., 2015; Acharya et al., 2016; Bhatia et al., 2002; Goggins &
Lo, 2012; Kadan-Lottick et al., 2003). It is evident that although non-Hispanic white children
have higher rates of incidence for ALL, they often experience the best outcomes in relation to the
disease. Numerous reasons, ranging from genetic to socioeconomic, could explain for these
results, however limited studies have been conducted to assess these speculations.
Sex. Many studies describe sex as having prognostic importance for childhood ALL, yet
it remains relatively unknown to what extent. In all cancer sites, males have had higher death
rates per 100,000 compared to females since the early 1900s (Siegel et al., 2016). And while sex
appears to have some prognostic importance, Khalid et al. (2010) did not find a difference in
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survival rates between males and females, ages 0-16 years, within their study. However, a
limitation of this study was the limited amount of females (n=11) included in the study compared
to males (n=35) (Khalid et al., 2010). Conversely, Teachey and Hunger (2013) stated within their
review of predictors of leukemia relapse that sex does have some level of prognostic importance,
but the extent of this importance remains undetermined. While some of this significance lies in
the fact that the incidence rate for all types of leukemia is higher in males than females, young
males may have worse outcomes in ALL specifically due to worse DNA indices, higher T-ALL
incidence rates, along with other biological differences compared to females (McCance et al.,
2010; Teachey & Hunger, 2013; Wang et al., 2015). Regardless of these differences, sex is
currently only seen to have limited prognostic value, and is generally not used to stratify the risk
of children with ALL (Teachey & Hunger, 2013).
Immunophenotype. Another important prognostic factor for children diagnosed with
ALL is immunophenotype. Immunophenotype is used to describe the presence of specific cell
molecules found on the surface of leukocytes, specifically lymphocytes in the case of ALL, in
order to direct treatment therapies for a child or adult with ALL (Hunger & Mullighan, 2015).
These surface molecules, otherwise known as cluster of differentiation (CD) markers, are used to
differentiate T-cells from B-cells, and ultimately guide treatment therapy in ALL patients (Shu &
Chen, 2005). Within children who have ALL, roughly 85% of cases are found to be of B-cell
origin, with the other 15% having T-cell origins (Hunger & Mullighan, 2015). For a variety of
reasons, T-cell ALL (T-ALL) has often been noted to be the least favorable type of childhood
ALL in terms of outcome status (Alperstein et al., 2015; Hunger & Mullighan, 2015; Lustosa de
Sousa et al., 2015; Teachey & Hunger, 2013). Hunger and Mullighan (2015) noted within their
study that this could be because those with T-ALL tend to also be males, black, and also present
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with higher leukocyte counts at diagnosis, along with having central nervous system involvement
or mediastinal masses, thus already having an unfavorable prognosis. Nevertheless, patients
diagnosed with T-ALL are subjected to more intense treatments due to its extremely aggressive
nature (Alperstein et al., 2015). Fortunately, the differences in survival outcome between
children who have B-cell ALL (B-ALL) and T-ALL have slowly decreased as treatments have
improved (Teachey & Hunger, 2013). However, in children that end up relapsing, those with BALL can still typically be cured, whereas relapsed T-ALL children have a very poor rates of
three-year event-free survival, with rates typically below 15% (Teachey & Hunger, 2013). Thus,
it is important that the diagnosis is accurate from the beginning and that treatment is adequate.
Cytogenetics. The understanding and relative importance of the cytogenetics of a
patient’s leukemic cells has vastly increased over the past several decades. Cytogenetic analysis
first began back in 1956 when it was discovered that a normal human cell housed 46
chromosomes (Harrison, 2009). As described by Harrison in 2009, the two primary
informational pieces that physicians look at following chromosomal analysis are if there is a
change in the number of chromosomes found within the leukemic cells or if there are changes in
the genetic make-up of the chromosomes within these cells. Cells that contain less than 44
chromosomes are often referred to as being “hypoploidy,” while cells containing more than 50
chromosomes are referred to as being “hyperploidy,” (Alperstein et al., 2015). Although the
National Cancer Institute does not currently recognize any cytogenetic abnormalities as being
prognostic factors for relapse in those diagnosed with ALL, various authors have noted that some
cytogenetic abnormalities have been associated with favorable or unfavorable prognosis
(Alperstein et al., 2015; Harrison, 2009; Hunger & Mullighan, 2015; National Cancer Institute,
n.d.; Pui, Mullighan, Evans, & Relling, 2012; Teachey & Hunger, 2013). Differences in the
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importance in various cytogenetic abnormalities were noted within each article, however it is
likely that new mutations were discovered throughout the years, creating these differences.
Nonetheless, children containing hyperploidy leukemic cells, as well as cells containing a
translocation between chromosomes 12 and 21 (creating a fusion protein known as ETV6RUNX1) were commonly associated with having a favorable prognosis (Alperstein et al., 2015;
Harrison, 2009; Hunger & Mullighan, 2015; Pui et al., 2012; Teachey & Hunger, 2013).
Children that had leukemic cells that were hypoploidy, or contained either a translocation
between chromosomes 9 and 22 (creating the BCR-ABL1 fusion protein), an MLL rearrangement,
or had an intrachromosomal amplification of chromosome 21 (iAMP21), were all identified as
having unfavorable chromosomal abnormalities (Alperstein et al., 2015; Hunger & Mullighan,
2015; Pui et al., 2012; Teachey & Hunger, 2013). Additional chromosomal abnormalities are
currently being evaluated for their prognostic value, with current estimations of their frequencies
and prognostic value being shown in Figure 1 (Pui et al., 2012; Teachey & Hunger, 2013).
Treatment adherence. Although many people tend to study the overall impact of the
factors that cannot be controlled, one factor that can often be controlled and has been shown to
impact overall survival and event-free survival is adherence to prescribed treatment therapies.
Treatment adherence can be influenced by socioeconomic status factors such as education and
income, however race and ethnicity can also play contribute to the effectiveness of a treatment
(Bhatia et al., 2012, 2014). For those diagnosed with ALL, treatment typically follows a similar
path as depicted in Figure 2, but can differ depending on the factors discussed previously
(Alperstein et al., 2015). Patient adherence becomes important during the maintenance phase of
treatment, which lasts between two and three years depending on the sex of the child with ALL
(Alperstein et al., 2015; Bhatia et al., 2012). In a study conducted by Bhatia et al. (2012),
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adherence rates to oral mercaptopurine, a drug commonly used within the maintenance phase of
ALL treatment, were studied in children under the age of 21 who were either of Caucasian or
Hispanic descent. At the end of the six month study, statistical analysis was completed to see if
there was an association between adherence rates and the risk of relapse (Bhatia et al., 2012).
Compared to children who adhered to the medication 95% or more of the time, children adhering
to the oral treatment only 90-94.9% of the time had four times greater risk of relapse, with those
adhering 85-89.9% and less than 85% of the time having 3.6-5 times greater risk of relapse
(Bhatia et al., 2012). Bhatia et al. (2014) found similar findings within a later study conducted,
however it was also discovered that African-American and Asian-American children had more
trouble adhering to treatment compared to Caucasian children, along with children living in lowincome households (<$50,000) compared to children living in higher-income households
(≥$50,000). African Americans had adherence rates of 87.1% ± 2.2% and Asian Americans had
adherence rates of 90.0% ± 2.5%, decreased from the 95.2% ± 0.6% adherence rates found in
non-Hispanic white children (Bhatia et al., 2014). Similarly, children living in low-income
households only had adherence rates of 89.7% ± 1.8% compared to the 95.3% ± 0.8% adherence
rates observed in higher income households. Thus, the importance of treatment adherence should
not be disregarded in studies that cannot obtain long-term follow-up information on treatment
adherence within their study population.
Summary
While a variety of factors have been explored within this literature review, others may
exist in addition to those already discussed. At the present, researchers have found that
socioeconomic status, race and ethnicity, leukocyte count at diagnosis, immunophenotype, age at
diagnosis, and sex have shown to have an impact on the survival of children with ALL, yet
differences in these influences have been seen among different populations. It is difficult to say
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which factor has the largest impact on ALL survival in children, as each factor can possibly
intertwine within another factor and increase the risk of poor outcomes in these children. In
general, the National Cancer Institute (n.d.) stratifies children into risk groups based only upon
leukocyte count at diagnosis and age, however as we have seen within the literature, other factors
also play an important role in the survival of children diagnosed with ALL.
Conclusion
A variety of factors affecting the survival of children diagnosed with ALL have been
introduced and examined within this literature review. Some of these variables have been wellestablished as prognostic factors, however others have rarely been studied or have shown various
levels of importance based upon the study population. For that reason, it is important to study
specific factors, such as socioeconomic status and race and ethnicity within the West Michigan
population of children diagnosed with ALL to establish the level of importance of these factors
for this particular population. Other factors are important to assess for within the study, as their
effects have shown value within other studies and should not be excluded. In the following
chapter, the methodology of this study will be discussed in further detail, and will relate back to
a majority of the variables discussed within this literature review.
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Figure 1. Approximate frequency of genetic subtypes found in leukemic cells among
children diagnosed with ALL. Blue colors indicate subtypes commonly found in children
diagnosed with B-ALL, while red colors indicate subtypes commonly found in children
diagnosed with T-ALL. Darker colors indicate subtypes that have been correlated with poor
prognosis. Data for chart retrieved from Pui, Mullighan, Evans, & Relling (2012).
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Figure 2. Standard treatment therapy progression for children with ALL.
Image from Alperstein et al. (2015).
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III. Methodology
Socioeconomic status has negatively influenced the outcomes of many diseases around
the world, however its association with five-year event-free survival in children with ALL has
not been frequently assessed within the United States. Furthermore, the association between
socioeconomic status in the population of West Michigan children diagnosed with ALL and
event-free survival has yet to be examined. Determining what risk factors influence five-year
event-free survival in West Michigan children ages 0-14 years is important to add to the limited
literature on this topic. Within this section, the overall study design for this research question,
including study participants, data collection methods, and data analysis methods, will be
discussed.
Participants/subjects
ALL accounts for roughly 26% of all cancers in children ages 0-14 years (American
Cancer Society, n.d.). In 2013, the United States Cancer Statistics Working Group (2016)
calculated the age-adjusted incidence rate for ALL in children ages 0-14 years to be 3.72 per
100,000 people, the highest incidence rate among all cancers. Thus, children ages 0-14 years
who were diagnosed with ALL between the years 2002-2011 were considered for this study. To
restrict the chance of differences in treatment affecting any associations found, the study
population was limited to children receiving treatment from the Helen DeVos Children’s
Hospital’s Pediatric Hematology and Oncology program. Then, only those residing within one of
the following Michigan counties (Allegan, Barry, Eaton, Ionia, Isabella, Kent, Lake, Mason,
Mecosta, Montcalm, Muskegon, Newaygo, Oceana, Osceola, or Ottawa) were included in the
study population. These counties are all supported by a nearby Spectrum Health hospital, which
provided treatment plans set-up in coordination with the Helen DeVos Children’s Hospital
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Pediatric Hematology and Oncology program (D. Dickens, personal communication, July 21,
2017). Children living outside of these counties were excluded from the study population due to
possible differences in treatment regimens.
The choice in the years that were retrospectively analyzed was done to allow for the
access of electronic medical records within the Spectrum Health system and a complete five-year
analysis of those diagnosed in 2011. No data has currently been presented on the association of
socioeconomic status and five-year event-free survival within this population, which provided
interest for the completion of this study.
Data Collection
Data access to the medical records at Helen DeVos Children’s Hospital required approval
through the Spectrum Health Institutional Review Board, Grand Valley State University’s
Human Research Review Committee, and the permission of the Helen DeVos Children’s
Hospital’s Pediatric Hematology and Oncology program. After approval by the above
institutions, a list of previously identified patients diagnosed with ALL was obtained from the
Helen DeVos Children’s Hospital’s Pediatric Hematology and Oncology program containing the
medical record numbers (MRNs) for these patients. The list of these MRNs was created on a
Microsoft Word file that was password protected on a password protected computer at Spectrum
Health’s Grand Rapids location. The file was transported as a paper file within a manila envelope
directly to the lead investigator which was then directly input into a correlation tool file within
Microsoft Excel. The paper file was shredded immediately upon transfer of the MRNs into the
correlation tool file. The computer file containing only the MRNs was destroyed upon transfer of
the file to the lead investigator.
Once the initial record of patient MRNs was input into the correlation tool file, Cerner
Millennium (Cerner Corporation, North Kansas City, MO) electronic medical record (EMR)
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system was utilized to complete chart reviews. Information received from the chart reviews
included date of diagnosis, leukocyte count at diagnosis, age at diagnosis via date of birth, race,
sex, immunophenotype, and the patient’s zip code at the present time. Date of relapse or date of
death, whichever occurred first, was also obtained for outcome measures if applicable. Data
viewed in Cerner Millennium was then recorded within the correlation tool file, a file that
contained all identifiable information that remained at the hospital for security purposes, with the
researcher being the only one able to access it if needed. Once all data had been entered into the
correlation tool file, a new data file, or final data set, was created so that it contained no
identifiable information. Identification numbers were used in place of identifiable MRNs, with
zip codes and dates of birth also being deidentified and removed from the new data file. The
correlation tool file was destroyed following the completion of the research study. The final data
set file to be stored following the completion of the study contained only de-identified
information. All files utilized for data collection purposes were password protected along with
being secured through a password protected computer. In addition to this, the correlation tool file
and final data set file were saved onto separate computers as well.
Data Analysis
Prior to starting statistical analysis, data obtained during data collection were deidentified
and recoded into categorical variables. The MRN for each patient was recoded starting from a
value of 0001 for the first patient, followed by subsequent numbers until all MRNs had been
recoded. Date of birth was used to identify what age the child was when they were diagnosed
with ALL, but then further recoded into age categories. Age at diagnosis was categorized into the
following categories: 1-4 years, 5-9 years, and ≥10 years of age. The categorization of race was
dependent on the distribution of the sample collected, thus categorization of the data fell into just
two groups: Caucasian and Other.
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United States Census information from 2000 was used to create a neighborhood
socioeconomic score for each child’s particular zip code based on the calculation utilized by
Diez Roux et al. (2001). The score encompassed three main areas connected with socioeconomic
status: education, income, and occupation. Data from the 2000 United States Census used for the
calculation of each neighborhood socioeconomic score based on each individual’s zip code
included median household income (log value), median value of housing units (log value),
percentage of households receiving interest, dividend, or net rental income, percentage of adults
25 years of age or older who had completed high school, percentage of adults 25 years of age or
older who had completed a college (bachelor’s) degree, and the percentage of employed persons
16 years of age or older in executive, managerial, or professional specialty occupations (Diez
Roux et al., 2001). Once all areas were assessed for each individual, z-scores for each variable
used within the neighborhood socioeconomic score were calculated by subtracting the mean
from the value of the variable and then dividing by the standard deviation. The z-score
represented the amount of deviations from the mean. For example, a calculated z-score value of
3.0 for the variable “percentage of households receiving interest, dividend, or net rental income
means” for that specific zip code shows that the Census value is three standard deviations above
the mean for all values obtained for that variable. Similarly, a z-score of -3.0 means the value is
three standard deviations below the mean value. Once all z-scores were calculated, individual
neighborhood socioeconomic scores were created by adding all z-scores from each variable
specific to that child’s zip code. For instance, if a child had z-scores of 1.9, 2.3, -1.2, 1.0, and
3.2, the neighborhood socioeconomic score for that child was equal to 7.2. Increasing scores
signified increased advantage among the neighborhood. Scores were stratified into three
socioeconomic groups (lowest, middle, and highest) based upon their standing among the other
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values, with the lowest third of scores being coded as the lowest socioeconomic group, and so
on. These scores were linked to the initial zip code recorded for each patient prior to the zip code
being removed.
Descriptive statistics were utilized to reflect the distribution of the predictive factors
collected based upon the socioeconomic tertiles created. Frequency and percent were reported
for categorical variables and mean (SD) for continuous variables. Five-year event-free survival
was assessed based on either relapse to any type of cancer or death for each child included in the
study. Differences in survival for each socioeconomic tertile were evaluated via Kaplan-Meier
survival analysis, generating Kaplan-Meier survival plots. Cox proportional hazard models were
conducted to explore the association between all factors studied. The initial unadjusted model
assessed the risk of relapse or death between the neighborhood socioeconomic tertiles created,
which was then adjusted for age, race, and sex. A final model included the additional adjustment
of leukocyte count at diagnosis and immunophenotype. Hazard ratios were calculated to
understand the risk of relapse or death between the various neighborhood socioeconomic tertiles.
The assumptions for proportional hazards were tested and were met. SAS 9.4 (SAS Institute,
Inc., Cary, NC) was used for all statistical analysis.
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IV. Results
During the investigation period between the years 2002-2011, 133 patients sought care
for ALL at the institution of interest. Twenty-one subjects did not meet inclusion criteria due to
residing outside of the selected study area. Among the 112 eligible subjects, eight were excluded
due to having missing information for age at diagnosis, leukocyte count at diagnosis, event
status, or a combination of these three variables. One additional individual was excluded from
the study population due to a lack of available information of their socioeconomic status, leaving
a total of 103 subjects to be utilized for data analysis. Figure 3 displays a flow diagram of the
exclusionary process among study subjects from the beginning of data collection for the time
period of interest to the time of data analysis.

133 Total Subjects
Investigated

21 subjects excluded
for being outside of
study zone
N=112
8 subjects excluded for
lack of available data
(age, WBC count, or
event status)
N=104
1 subject excluded due
to missing SES data
103 Subjects Utilized
for Data Analysis
Figure 3. Flow diagram of subject inclusion during the study period of
interest from the beginning of data collection to the time of data analysis.
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Descriptive Statistics
Among the 103 study participants that were included within the data analyses, 61.2%
were male. Mean age at diagnosis was almost six years (M = 5.91, SD = 3.71) with a median of
five years (IQR=6.00). Age was later categorized into three different categories, ages 1-4 years,
5-9 years, and ≥10 years, with most of the population falling into the age range of 1-4 years
(46.6%). The study population primarily identified as being Caucasian (80.6%) and was most
commonly diagnosed with B-ALL (84.5%). A full summary of the descriptive characteristics of
the study population can be found in Table 2. Following the calculation of the neighborhood
socioeconomic scores, the mean score of the population was 0.18 (M = 0.18, SD = 4.75), with a
median score of -0.11 (IQR = 8.02). Neighborhood socioeconomic scores ranged from -8.61 to
15.9.
Table 2.
Descriptive statistics for the 103 eligible ALL cases from 2002-2011
Demographic Variable
N (%)
M (SD)
Age at diagnosis (years)
5.91 (3.71)
1-4
48 (46.7%)
5-9
32 (31.1%)
10+
23 (22.3%)
Sex
Male
63 (61.2%)
Female
40 (38.8%)
Race
White
83 (80.6%)
Hispanic
12 (11.7%)
Other
8 (7.8%)
Immunophenotype
B-ALL
87 (84.5%)
T-ALL
15 (14.6%)
Missing
1 (1.0%)
9

Leukocyte count at diagnosis (x10 /L)
36.8 (39.2)
Note. Based on 103 study subjects utilized for data analysis. B-ALL= Bcell acute lymphoblastic leukemia; T-ALL = T-cell acute lymphoblastic
leukemia
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Survival Analyses
During the five-year follow-up period in which subjects were assessed, a total of eleven
participants (10.7%) experienced an event, defined as either relapsing into any form of cancer or
death. All events that were recorded were relapses, with one death occurring after an initial
relapse. Among the subjects that experienced an event, two subjects were from the lowest
neighborhood socioeconomic tertile, with the middle tertile having three children experience an
event, and the highest tertile having six children that experienced an event. Kaplan-Meier
survival analysis did not show a difference in survival between the different socioeconomic
tertiles assessed, χ2 (2, N = 103) = 2.70, p = 0.26, as demonstrated by Figure 4.
Three sequential Cox Proportional Hazards models were conducted for this study. The
proportional hazards assumption was checked and met for the initial unadjusted model. The
results for this assumption can be found in the Appendix. In the initial unadjusted Cox
Proportional Hazards model, the risk of relapsing or dying within five years varied across the
tertiles of socioeconomic scores, however these differences did not prove to be statistically
significant. Children who were categorized as being within the middle tertile saw a 1.48 times
greater risk of relapsing or dying within five years of their diagnosis compared to children of the
lowest tertile (HR = 1.48, p = 0.67, 95% CI [0.25, 8.86]), while children who were categorized as
being within the highest, or most affluent, tertile had a 3.17 times greater risk of relapse or death
within five years compared to children who were categorized as being within the lowest
socioeconomic tertile (HR = 3.17, p = 0.16, 95% CI [0.64, 15.7]).
When adjusting for the demographic variables age, race, and sex, the association between
neighborhood socioeconomic score and relapse or death attenuated. Children that were in the
middle tertile of the calculated neighborhood socioeconomic scores had a 1.26 times greater risk
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of relapsing or dying within five years after adjusting for age, race, and sex (HR = 1.26, p = 0.81,
95% CI [0.19, 8.33]) compared to children in the lowest tertile. Children categorized into the
highest tertile were at 3.02 times greater risk of having an event within five years after adjusting
for age, race, and sex as well (HR = 3.02, p = 0.19, 95% CI [0.59, 15.5]) compared to children in
the lowest tertile. However, neither of these associations reached the threshold for statistical
significance. Among the demographic variables analyzed and adjusted within the model,
children above the age of four-years, non-whites, and males were all at greater risk of
experiencing an event within five years of their diagnosis compared to their counterparts,
however none of these results were statistically significant (Table 3).
The final, full model contained all the variables collected for the study: neighborhood
socioeconomic scores, age, race, sex, leukocyte count at diagnosis, and immunophenotype. After
adjusting for these variables, the association between neighborhood socioeconomic status and
relapse or death further attenuated. Similar to the previous models explored, when compared to
the lowest socioeconomic tertile, both the middle tertile, and the highest tertile had a greater risk
of relapsing or dying within five years of the initial diagnosis. The middle tertile saw a 1.27
times greater risk of having an event within five years of diagnosis (HR = 1.27, p = 0.80, 95% CI
[0.19, 8.48]), while the highest tertile saw a 2.95 times greater risk within five years (HR = 2.95,
p = 0.20, 95% CI [0.57, 15.3]), when adjusting for all the variables included within the full
model. In addition to these findings, children over the age of four-years, non-whites, males, and
those diagnosed with B-ALL were all found to have a greater risk of relapsing or dying within
five years compared to their counterparts. None of these findings proved to be statistically
significant, however. Table 3 contains the full results from each of the respective Cox
Proportional Hazards models discussed above.
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Figure 4. Kaplan-Meier estimates of five-year event-free survival for children diagnosed with
ALL by calculated neighborhood socioeconomic score tertiles. Log-rank test of homogeneity:
χ2 = 2.70, p = 0.26. Blue numbers indicate the number of children within the lowest

socioeconomic tertile who did not have an event (event-free survival) at each point in time,
with red numbers being indicative of event-free survival within the middle socioeconomic
tertile and green numbers being indicative of event-free survival in the highest socioeconomic
tertile.
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0.36

0.49

0.58

0.17
0.12

0.80
0.20

p

1.00 [1.00, 1.01] 0.46
Leukocyte Count at Diagnosis (x109/L)
Note . ALL = acute lymphoblastic leukemia; HR = hazard ratio; CI = confidence interval
*Adjusted for neighborhood socioeconomic status scores (based on tertiles created), age, race, and sex
†Adjusted for neighborhood socioeconomic status scores (based on tertiles created), age, race, sex, immunophenotype, and leukocyte count at
diagnosis.

Table 3.
Cox Proportional Hazards model results related to five year event-free survival in children ages 0-14 years with ALL
Model 1
Model 2*
Model 3†
Variables
HR
[95% CI]
p
HR
[95% CI]
p
HR
[95% CI]
Neighborhood Socioeconomic
Score Tertile
Reference
Lowest
Reference
Reference
Middle
1.48 [0.25, 8.86] 0.67
1.26 [0.19, 8.33] 0.81
1.27 [0.19, 8.48]
Highest
3.17 [0.64, 15.7] 0.16
3.02 [0.59, 15.5] 0.19
2.95 [0.57, 15.3]
Age (years)
Reference
1-4
Reference
5-9
2.44 [0.53, 11.2] 0.25
2.92 [0.63, 13.5]
10+
2.99 [0.64, 13.9] 0.16
3.48 [0.73, 16.5]
Race
Reference
Caucausian
Reference
Other
1.46 [0.36, 5.94] 0.60
1.48 [0.36, 6.05]
Sex
Reference
Female
Reference
Male
1.51 [0.46, 5.01] 0.50
1.54 [0.46, 5.19]
Immunophenotype
Reference
T-ALL
B-ALL
3.58 [0.23, 56.7]

V. Discussion
A difference in five-year event-free survival was not detected between those of lower
socioeconomic standing and those of higher socioeconomic standing when studying children,
ages 0-14 years, who were diagnosed with ALL within West Michigan. While many studies have
previously shown that those of lower socioeconomic standing are more likely to have worse
health outcomes for a variety of health issues, little research has been done to describe this
association among those diagnosed with ALL, especially within children (Demakakos et al.,
2008). This study was one of the few to look at this association among children diagnosed with
ALL in the United States, and the first to try and understand the association within the West
Michigan area. Those of higher socioeconomic standing within the population under
investigation were found to have a greater risk of relapsing or dying within five years of their
initial ALL diagnosis, but not statistically. These results differ from previous studies conducted
in the United States, which found protective effects of the higher socioeconomic class (Abrahão
et al., 2015; Bona et al., 2016; Kent et al., 2009; Petridou et al., 2015). The differences in these
findings suggest that more research within this field should continue to be conducted to better
understand the association of interest.
Finding that patients from higher socioeconomic neighborhoods were more likely to
experience relapse or death compared to those of living within lower socioeconomic
neighborhoods was contrary to the original hypothesis. Although unanticipated, the results of this
study add to the limited current literature, especially within the United States. The study was able
to assess for a multitude of possible confounding variables, increasing the ability to understand
the true association between socioeconomic status and five-year event-free survival among the
population of interest. And while the small sample size (N=103) likely contributed to an
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underpowered study, the results can further the discussion between the association of
socioeconomic status and health-related outcomes, especially among those diagnosed with ALL.
Prior to the start of data analysis, it was initially hypothesized that those of lower socioeconomic
standing would be more likely to experience relapse or death, as those of higher socioeconomic
status tend to have better overall health and health outcomes, compared to those of lower
socioeconomic standing (Lynch et al., 2004). However, in 1997, Greaves described that
advances in hygiene and changes to the typical contact children had with one another via daycare, particularly among those of higher socioeconomic status, may contribute to decreased
exposure to early childhood infectious agents. This decreased exposure to infectious agents may
leave children to be more at risk for diseases such as ALL due to the lack of immune system
regulation during the child’s early childhood years. In addition to this, it was hypothesized that
mothers living in developed areas may be less likely to pass on immunity to their newborn child
if they were not exposed to various infectious agents prior to, or during the pregnancy (Greaves,
1997). A case-control study utilizing data from the CCR, along with another case-control study
using data collected around the world, were able to support the hypothesis that early childhood
infections may be able to protect individuals from developing ALL (Marcotte, Ritz, Cockburn,
Yu, & Heck, 2014; Rudant et al., 2015). These studies were able to look at a variety of variables
related to early childhood exposure to infections, further helping to support the hypothesis
discussed by Greaves (1997) and the findings of our study.
In the study completed by Rudant et al. (2015), researchers tried to gain an understanding
of the effects of breastfeeding, day care attendance, and birth order on the risk of a child
developing ALL (Rudant et al., 2015). It was found that breastfeeding for six months or longer,
higher birth order, and day-care attendance within the first year of life all had a protective effect
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against the development of ALL in children, likely due to the increased immunity provided by
the mother during breastfeeding and due to the increased exposure to infectious agents via
siblings and other children (Rudant et al., 2015). Marcotte et al. (2014) also looked at various
markers related to the possibility of exposure to infections and risk of ALL later in life. Variables
analyzed within Marcotte et al.’s (2014) large case-control study included birth month, birth
order, and the time of birth in comparison to influenza and common respiratory virus cycles. It
was determined that those born during the spring and summer months, and those exposed to the
common childhood viruses later in life, were at increased risk of developing ALL (Marcotte et
al., 2014). Birth order also appeared to be a protective factor when looking at the risk of the
development of ALL, as there was a decreased risk of ALL among those higher within their
family’s birth order (Marcotte et al., 2014). This is likely due to the fact that as a child is born
higher into the birth order, a child is exposed to more infectious agents from his or her siblings
born before him or her. Nonetheless, the findings seen within the studies completed by Marcotte
et al. (2014) and Rudant et al. (2015) support the early hypothesis created by Greaves (1997) that
early childhood exposures to infectious agents may reduce the risk of a child getting ALL. These
studies, along with future research within this area, may help to explain why children of higher
socioeconomic status may be at greater risk of relapsing or dying compared to children with
lower socioeconomic backgrounds.
Strengths
The overall design of the study helped to create several strengths. By identifying the
location of all the hospitals within the Spectrum Health organization, it was possible to limit the
study population to only counties located near a Spectrum Health facility, limiting the chance
that an individual may seek treatment at a facility other than Spectrum Health during the study
period. This also led to better retention and tracking of the patients included within the study and
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helped to limit travel distance to treatment facility as a potential confounder. Furthermore, the
sampling method utilized within the study allowed for a population that was distributed similar
to previous studies that had been completed. Hunger and Mullighan (2015) noted that more
males tended to be diagnosed with ALL compared to females (male to female ratio of 55% to
45%), similar to the ratio found within the study (61% males, 39% females). The distribution of
the various races observed within the study was similar to the much larger study (N=14,192)
completed by Hossain, Xie, and Mccahan (2014), as 83% of children within their study were
Caucasian, compared to the 81% of children identified as being Caucasian within this study.
After further discussion of the population utilized for the study, it was determined that the study
was also distributed as expected by the doctors within the Helen DeVos Children’s Hospital’s
Pediatric Hematology and Oncology program (D. Dickens, personal communication, July 21,
2017). Along with the strengths listed above, the short time period of interest allowed for fewer
changes in the treatment protocol to occur over the study period, further limiting the chance that
changes in treatment could have been a confounder within the study.
Limitations
With fewer subjects eligible for the study than previously expected, the limited sample
size (N = 103) available for statistical analysis largely impacted the power to detect statistically
significant findings. The lack of events that occurred within the population, although showing
positive outcomes for those diagnosed with ALL, may have also contributed to the lack of an
observed association between neighborhood socioeconomic scores and event-free survival in
children diagnosed with ALL. The small sample size also limited the power available to be able
to explore possible interactions between various variables collected during the data collection
process. As discussed by Vanderweele and Knol (2014), in order to look into the interaction
between various variables included within the study, a larger sample size would be necessary.
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Individual-level socioeconomic status information was not obtained from each child
included within the study, however the neighborhood socioeconomic score used to look at the
association of interest has been shown to be predictive of various health-related outcomes, even
after controlling for individual and family-level socioeconomic status (Chen & Paterson, 2006).
Individual-level insurance status was also not able to be obtained during the final data analysis
due to inconsistent reporting within the medical record. Individual treatment plans were also
unable to be viewed, leaving the possibility for selection bias in who sought care at Spectrum
Health, to influence the results. Lastly, the impact of genetic mutations within the leukemic cells
found in each patient could not be assessed for, as information regarding the genetic analysis of
the leukemic cells could not be uniformly obtained for all individuals included within the study.
In addition to this, cytogenetic analysis has improved and changed throughout the years under
investigation within this study, thus comparing each patient’s cytogenetics using the same
threshold would be unclear, as there were changes in the testing and reporting of these genetic
factors during the study period.
Recommendations for Practice
As the survival rate for those diagnosed with ALL has risen from below 10% during the
1960s, to roughly 90% over the past several decades, changes in the relative treatment of the
disease are not a necessity, however it is important to continue to address the impacts of
treatment inequalities (Lustosa de Sousa et al., 2015; Nguyen et al., 2008; Wang et al., 2015).
Petridou et al. (2015) found within their meta-analysis that although improvements have been
made in the treatment of ALL, those within lower socioeconomic settings are less likely to be
able to take advantage of these improvements. However, improvements in caring for those of
lower socioeconomic status continue to be made in the healthcare setting, as various hospitals are
incorporating the use of social workers and other faculty members to better facilitate an open line
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of communication between physicians and families, along with addressing additional needs
certain families might have. Currently, Spectrum Health’s Helen DeVos Children’s Hospital’s
Pediatric Hematology and Oncology programs is able to help provide transportation and support
the payment of co-pays for various individuals who seek treatment within their clinic, helping to
decrease the chance that socioeconomic status may lead to different ALL outcomes (personal
communication, D. Dickens, July 21, 2017). Additional improvements within the practice, such
as strictly enforcing medication adherence, ensuring that follow-up care is completed, and the
quick identification of new possible ALL cases, have also helped to limit and potentially
overcome differences between the various socioeconomic groups that exist (personal
communication, D. Dickens, July 21, 2017). The further development of such practices may lead
to hospital systems being able to overcome socioeconomic status disparities seen in many health
outcomes.
In addition to the improvements described above, the state of Michigan continues to fund
the “Children’s Special Health Care Services” program, as those diagnosed with roughly 2,700
severe diseases, such as ALL, are eligible to receive financial assistance regardless of
socioeconomic status as long as the child is a resident of the state of Michigan and under the age
of 21 (Michigan Department of Health and Human Services, 2017). Nonetheless, while
improvements in the care of all socioeconomic backgrounds have been made via policies and
healthcare practices, it is imperative that continual research be conducted to better understand the
association between socioeconomic status and relapse and/or death in children diagnosed with
ALL. Limited research still exists across the United States for public health officials to be able to
understand the true impact of socioeconomic status on ALL outcomes. It may also be of interest
to further investigate the impacts that improved hygiene and changes to childcare have had on
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various immune-mediated diseases, such as ALL, as this field of research may explain why those
of higher socioeconomic standing were at greater risk of relapse within our study. With many
major healthcare services already in place for those of all socioeconomic backgrounds, the
continuation and adaptation of these services to better meet the needs of all levels of wealth is
important to improve the health of children diagnosed with ALL.
Future Directions
While the association of interest did not prove to be statistically significant, changes
within the methodology of this study can be made to improve the statistical power of a future
study. It is proposed that by gaining a larger population to study, possibly by sampling all
children within the state of Michigan, ages 0-14 years, who were diagnosed with ALL, a better
understanding of the research question under investigation can be gained. This can be completed
by working with other hospital systems across the state, or by utilizing data collected by the
Michigan Cancer Surveillance Program. However, differences in treatment may occur across the
state, potentially confounding the association of interest. It may also be difficult to accurately
assess for socioeconomic status depending on the method chosen from those described above,
thus it is important to explore both avenues of study adequately. Nevertheless, the research
question of interest for this study has been understudied within the United States, thus the
completion of a larger study would greatly benefit those researching, treating, or undergoing
treatment within the pediatric ALL community.
It would also be advantageous for future research to look further into the differences in
event-free survival based on socioeconomic status in other areas of the United States, as each
area has different racial compositions and hospital system availability compared to West
Michigan. Currently, one of the Office of Disease Prevention and Health Promotion's (2014)
Healthy People 2020 goals is to achieve equality in its medical care for all people, as the Agency
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for Healthcare Research and Quality (AHRQ) (2014) still reports differences in the quality of
healthcare received by different racial groups. Additionally, Horwitz (2005) discussed how
different types of hospitals, specifically for-profit compared to non-profit, often have differences
in the services and quality of services they provide. With many areas across the United States
having different racial compositions and hospital systems compared to that of West Michigan, it
is important to understand how these differences may affect ALL outcomes. The AHRQ reported
in 2014 that although improvements in treating disparities among minority populations has
improved, access and quality of care remain issues for many minorities. Language barriers and
healthcare insurance status were reported as major barriers for many minorities in gaining access
to care, however the predominately non-Hispanic white population seen within West Michigan
may not see these barriers compared to other areas around the United States that are composed
primarily of minority races (AHRQ, 2014). Similarly, for-profit hospitals have been shown to be
less likely to provide services that are not profitable compared to their counterparts, even if the
need for that service is evident within the community (Horwitz, 2005). Private hospitals also
tended to serve higher-income individuals compared to those that have lower socioeconomic
standing, possibly suggesting that there may be a difference in who is more likely to seek
treatment at a specific health institution (Basu, Andrews, Kishore, Panjabi, & Stuckler, 2012).
Thus, future research should further investigate other areas of interest across the United States,
especially ones that are composed of different racial groups and hospital systems compared to
those seen here in West Michigan.
In addition to the suggestions given above, following the discussion of the study’s
findings, it would be beneficial to continue the investigation on the impact of early infectious
disease exposures on the risk of developing ALL and/or relapsing or dying from the disease once
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diagnosed. The studies that have been completed within this context of study have shown
promising results, similar to those investigating the importance of socioeconomic status in
identifying those who may relapse or die from ALL, however a limited number of studies have
been completed within this field of research. Looking further into the association between early
childhood infectious exposures and the development of ALL may help to identify new risk
factors for the development of this disease or risk factors for possible relapse or death among
those already diagnosed. As improvements in hygiene and changes to childcare continue to
occur, the need for ongoing research in this field is important for those who are diagnosed with
ALL, may become diagnosed with ALL, along with others who may suffer from other immunemediated diseases.
Conclusions
The results of this study show that there is a need to continue the research efforts being
put forth to look at the association of socioeconomic status and event-free survival in children
diagnosed with ALL, particularly within the United States. Our study showed that children living
in areas of greater socioeconomic status may be more likely to experience either a relapse or
death from their ALL compared to children of lower socioeconomic status, differing from the
results observed within other studies completed within the United States (Abrahão et al., 2015;
Bona et al., 2016; Kent et al., 2009; Petridou et al., 2015). These differences may be able to be
explained by decreases in early childhood exposure to infectious agents caused by improvements
in hygiene and changes in childcare over the years. Further research should be conducted in
looking at the association between socioeconomic status and event-free survival in children
diagnosed with ALL, along with exploring other relevant areas mentioned previously. It is
important to continue research in this field, as well as in other areas of healthcare research, in
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order to decrease the differences observed between the health outcomes of the various
socioeconomic backgrounds that exist.
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Appendix
Cox Proportional Hazard Model Assumption Testing
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